Publications by authors named "Aram Musaelyan"

Claim this Profile
M
Molecularly guided precision therapy in metastatic adamantinoma: a case report.
Aram A Musaelyan, Svetlana V Odintsova, Alexander O Ivantsov, Evgeny N Imyanitov, Sergey V Orlov

Per Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of immune checkpoint inhibitors rechallenge and metronomic cyclophosphamide with or without bevacizumab in metastatic nonsmall cell lung cancer.
Aram A Musaelyan, Svetlana V Odintsova, Magaripa A Urtenova, Ekaterina P Solovyova, Liliana V Kindyalova

Anticancer Drugs· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive markers of response to immune checkpoint inhibitor rechallenge in metastatic non-small cell lung cancer.
Aram A Musaelyan, Svetlana V Odintsova, Karina A Musaelyan, Magaripa A Urtenova, Ekaterina P Solovyova

Explor Target Antitumor Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to trametinib, hydroxychloroquine, and bevacizumab in a young woman with -mutated metastatic intrahepatic cholangiocarcinoma: a case report.
Aram A Musaelyan, Ekaterina M Anokhina, Alina I Turdubaeva, Natalia V Mitiushkina, Anastasia N Ershova

Explor Target Antitumor Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical predictors of response to single‑agent immune checkpoint inhibitors in chemotherapy‑pretreated non‑small cell lung cancer.
Aram A Musaelyan, Fedor V Moiseyenko, Tancholpon E Emileva, Ani P Oganesyan, Karina A Oganyan

Mol Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory and autoimmune predictive markers of response to anti-PD-1/PD-L1 therapy in NSCLC and melanoma.
Aram A Musaelyan, Sergey V Lapin, Margarita A Urtenova, Svetlana V Odintsova, Ivan V Chistyakov

Exp Ther Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vimentin as antigenic target in autoimmunity: A comprehensive review.
Aram Musaelyan, Sergey Lapin, Vladimir Nazarov, Olga Tkachenko, Boris Gilburd

Autoimmun Rev· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis